Chemotherapy-induced nausea and vomiting in Portugal: incidence versus healthcare provider estimations and effect on quality of life

By Dinis Joséé   Wisniewski Tami   Moreira Antóónio   Raposo Joãão   Ma Larry   Burke Thomas A  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 595-602

Future Medicine

Access to resources Recommend Favorite

Chemotherapy-Induced Nausea, Vomiting, and Fatigue – the Role of Individual Differences Related to Sensory Perception and Autonomic Reactivity

By  

Psychotherapy and Psychosomatics, Vol. 76, Iss. 6, 2007-10 ,pp. : 376-384

Karger

Access to resources Recommend Favorite

Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy‐induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 10, 2015-10 ,pp. : 911-914

John Wiley & Sons Inc

Access to resources Recommend Favorite

Trajectory and risk factors for chemotherapy‐induced nausea and vomiting in Asian patients with head and neck cancer

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 9, 2015-09 ,pp. : 1349-1357

John Wiley & Sons Inc

Access to resources Recommend Favorite

Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy‐induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 919-8172, Iss. 10, 2015-10 ,pp. : 911-914

John Wiley & Sons Inc

Access to resources Recommend Favorite